Cellevate

Cellevate is a privately held biotech company based in Lund, Sweden, founded in 2015 as a spin-out from Lund University. The company has developed the Cellevat3d® platform, a proprietary, cellulose-based nanofiber technology that serves as a microcarrier for high-density cell culture in bioreactors. Its primary value proposition is driving >10-fold increases in viral vaccine and vector yields while offering scalability, sustainability, and process simplification. Cellevate is ISO 9001:2015 certified, employs GMP processes, and is transitioning from R&D to early commercialization with its first products for viral vaccine and lentiviral vector production.

Cellevat3d®: A proprietary, cellulose-based nanofiber microcarrier platform for high-density 3D cell culture in bioreactors. It is designed to significantly increase yield in viral vector and vaccine production, is biodegradable, scalable, and integrates into standard stirred-tank bioreactors.

Cellevate competes with established suppliers of microcarriers and cell culture substrates, such as Cytiva (Cytodex), Corning, Sartorius, and Thermo Fisher Scientific. Its key differentiators are the nanofiber structure for higher cell density, the biodegradable cellulose material, and the claimed order-of-magnitude yield improvements.